Schedule 13G ownership disclosure

VIRIOS THERAPEUTICS INC

Security class unavailable · CUSIP: 92829J104

Event date: 2024-02-13

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
882,400
Percent of class
4.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001654954-24-001683
Form type
SC 13G/A
Filer
Corday Brian David
CIK
CIK 1322787
Filed
Feb 13, 2024
Reporting period
Feb 13, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub